3M acquires private wound-care company, Acelity, for $6.7B*—the largest acquisition in 3M’s history: https://finance.yahoo.com/news/3m-acquire-acelity-inc-103000219.html https://www.wsj.com/articles/3m-to-buy-acelity-for-enterprise-value-of-6-7-billion-11556795031 https://finance.yahoo.com/news/3m-biggest-deal-ever-could-163110873.html The Bloomberg piece (bottom link above), which I’m inclined to agree with, is bearish on the deal for reasons that are mostly inferential. The acquisition will add $0.25/sh to non-GAAP EPS during first 12 months following closing (but will reduce GAAP EPS, of course). This news was announced yesterday (Thursday). *Including assumption of debt.